UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Inhibitory Activities of Antioxidant Flavonoids from Tamarix gallica on Amyloid Aggregation Related to Alzheimer’s and Type 2 Diabetes Diseases

Biological and Pharmaceutical Bulletin, 2017/02/01, Vol.40(2), pp.238-241

2017

Link zum Volltext

Verfügbarkeit prüfen

Semisynthesis and Structure–Activity Studies of Uncarinic Acid C Isolated from Uncaria rhynchophylla as a Specific Inhibitor of the Nucleation Phase in Amyloid β42 Aggregation

Journal of natural products (Washington, D.C.), 2016-10, Vol.79 (10), p.2521-2529

2016

Link zum Volltext

Verfügbarkeit prüfen

Activity-differential search for amyloid-β aggregation inhibitors using LC-MS combined with principal component analysis

Bioorganic & medicinal chemistry letters, 2022-04, Vol.61, p.128613-128613, Article 128613

2022

Link zum Volltext

Verfügbarkeit prüfen

Detection of Dietary Chalcone and Flavonoid Metabolites in Mice Using UPLC–MS/MS and Their Modulatory Effects on Amyloid β Aggregation

Journal of agricultural and food chemistry, 2023-10, Vol.71 (39), p.14289-14299

2023

Link zum Volltext

Verfügbarkeit prüfen

Searching for Natural Products That Delay Nucleation Phase and Promote Elongation Phase of Amyloid β42 toward Alzheimer’s Disease Therapeutics

ACS chemical neuroscience, 2021-09, Vol.12 (18), p.3467-3476

2021

Link zum Volltext

Verfügbarkeit prüfen

Structural insights into mechanisms for inhibiting amyloid β42 aggregation by non-catechol-type flavonoids

Bioorganic & medicinal chemistry, 2016-01, Vol.24 (2), p.304-313

2016

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic analyses of the suppression of amyloid β42 aggregation by apomorphine

Bioorganic & medicinal chemistry, 2018-05, Vol.26 (8), p.1538-1546

2018

Link zum Volltext

Verfügbarkeit prüfen

Role of the carboxy groups of triterpenoids in their inhibition of the nucleation of amyloid β42 required for forming toxic oligomers

Chemical communications (Cambridge, England), 2018-06, Vol.54 (49), p.6272-6275

2018

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and characterization of the amyloid beta 40 dimer model with a linker at position 30 adjacent to the intermolecular beta -sheet region

Biochemical and biophysical research communications, 2015-10, Vol.466 (3), p.463-467

2015

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and biochemical characterization of quasi-stable trimer models of full-length amyloid β40 with a toxic conformation

Chemical communications (Cambridge, England), 2019, Vol.55 (2), p.182-185

2019

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and biochemical characterization of quasi-stable trimer models of full-length amyloid β40 with a toxic conformationElectronic supplementary information (ESI) available: Experimental procedures and Fig. S1-S3. See DOI: 10.1039/c8cc08618d

2018-12

Link zum Volltext

Verfügbarkeit prüfen

Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone in vitro and in vivo

RSC chemical biology, 2022-11, Vol.3 (12), p.1380-1396

2022

Link zum Volltext

Verfügbarkeit prüfen

Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone and

RSC chemical biology, 2022-11, Vol.3 (12), p.138-1396

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthetic Models of Quasi-Stable Amyloid β40 Oligomers with Significant Neurotoxicity

ACS chemical neuroscience, 2017-04, Vol.8 (4), p.807-816

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthetic and biochemical studies on the effect of persulfidation on disulfide dimer models of amyloid β42 at position 35 in Alzheimer's etiology

RSC advances, 2020-05, Vol.1 (33), p.1956-19512

2020

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis

Scientific reports, 2016-07, Vol.6 (1), p.29038-29038, Article 29038

2016

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and characterization of the amyloid β40 dimer model with a linker at position 30 adjacent to the intermolecular β-sheet region

Biochemical and biophysical research communications, 2015-10, Vol.466 (3), p.463-467

2015

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibody with conformational specificity for a toxic conformer of amyloid [beta]42 and its application toward the Alzheimer's disease diagnosis

Scientific reports, 2016-07, Vol.6, p.29038

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)

Sprache

Englisch
(16)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Alzheimer's Disease
(6)
Neurotoxicity
(6)
Science & Technology
(6)
Aggregation
(5)
Alzheimer’s Disease
(5)
Humans
(5)
Life Sciences & Biomedicine
(5)
Amyloid Β
(4)
Chemistry
(4)
Molecular Structure
(4)
Alzheimer Disease - Metabolism
(3)
Amyloid Beta-Peptides - Antagonists & Inhibitors
(3)
Amyloid Beta-Peptides - Chemistry
(3)
Amyloid Β-Protein
(3)
Dimers
(3)
Oligomer
(3)
Oligomers
(3)
Peptide Fragments - Chemistry
(3)
Physical Sciences
(3)
Structure-Activity Relationship
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibitory Activities of Antioxidant Flavonoids from Tamarix gallica on Amyloid Aggregation Related to Alzheimer’s and Type 2 Diabetes Diseases

Semisynthesis and Structure–Activity Studies of Uncarinic Acid C Isolated from Uncaria rhynchophylla as a Specific Inhibitor of the Nucleation Phase in Amyloid β42 Aggregation

Activity-differential search for amyloid-β aggregation inhibitors using LC-MS combined with principal component analysis

Detection of Dietary Chalcone and Flavonoid Metabolites in Mice Using UPLC–MS/MS and Their Modulatory Effects on Amyloid β Aggregation

Searching for Natural Products That Delay Nucleation Phase and Promote Elongation Phase of Amyloid β42 toward Alzheimer’s Disease Therapeutics

Structural insights into mechanisms for inhibiting amyloid β42 aggregation by non-catechol-type flavonoids

Mechanistic analyses of the suppression of amyloid β42 aggregation by apomorphine

Role of the carboxy groups of triterpenoids in their inhibition of the nucleation of amyloid β42 required for forming toxic oligomers

Synthesis and characterization of the amyloid beta 40 dimer model with a linker at position 30 adjacent to the intermolecular beta -sheet region

Synthesis and biochemical characterization of quasi-stable trimer models of full-length amyloid β40 with a toxic conformation

Synthesis and biochemical characterization of quasi-stable trimer models of full-length amyloid β40 with a toxic conformationElectronic supplementary information (ESI) available: Experimental procedures and Fig. S1-S3. See DOI: 10.1039/c8cc08618d

Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone in vitro and in vivo

Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone and

Synthetic Models of Quasi-Stable Amyloid β40 Oligomers with Significant Neurotoxicity

Synthetic and biochemical studies on the effect of persulfidation on disulfide dimer models of amyloid β42 at position 35 in Alzheimer's etiology

Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis

Synthesis and characterization of the amyloid β40 dimer model with a linker at position 30 adjacent to the intermolecular β-sheet region

Monoclonal antibody with conformational specificity for a toxic conformer of amyloid [beta]42 and its application toward the Alzheimer's disease diagnosis

Suchergebnisse filtern